From the radiographs provided by the patient, lucency was noted around the phalangeal implant indicating loosening.The cause for reported issue is unknown.The device is unable to be returned for investigation as it remains implanted in the patient.The device history records of the implant lots in question were reviewed and noted that each lot was built to established specifications.The non-conforming parts were appropriately identified and segregated accordingly.The instructions for use (ifu) document states that this type of event can occur and all risks are addressed in the risk documentation.Several factors such as stress/ physical loads on the implants, vascularity of the implantation site, surgical techniques employed during implantation, patient factors (such as age, current state of the immune system, bone quality, and sensitivity to device materials), and patient post-op compliance to rehabilitation procedures etc., can have impact on the functional effectiveness of the implanted devices.The implant materials and combinations have decades of history for use in joint replacement applications.Also, the implant materials have been evaluated for biocompatibility to demonstrate safety for intended purposes.Per initial information, the patient is currently planning on a revision to a fusion.The patient has since not responded to follow-up attempts.Should arthrosurface receive any further information regarding this event in future, it will be documented and reported accordingly through a supplemental mdr.Below is the information related to the implanted device.Part # 9p15-pb01-w , lot # 75gf0711, mfg.Date: 08/10/2016, exp.Date: 08/10/2023; part # 9p15-s180-w , lot # 75hf0209, mfg.Date: 08/08/2016 , exp.Date: 08/08/2021.
|